Table 1 Demographic characteristics of participants.
Characteristic | BNT162b2 | Placebo | Overall | ||
|---|---|---|---|---|---|
20–64 years of age (N = 97) | 65–85 years of age (N = 22) | 20–64 years of age (N = 33) | 65–85 years of age (N = 8) | (N = 160) | |
Male, n (%) | 50 (51.5) | 9 (40.9) | 16 (48.5) | 6 (75.0) | 81 (50.6) |
Race, n (%) | |||||
Asian | 97 (100.0) | 22 (100.0) | 33 (100.0) | 8 (100.0) | 160 (100.0) |
Ethnicity, n (%) | |||||
Non-Hispanic/non-Latinx | 97 (100.0) | 22 (100.0) | 33 (100.0) | 8 (100.0) | 160 (100.0) |
Racial designation, n (%) | |||||
Japanese | 97 (100.0) | 22 (100.0) | 33 (100.0) | 8 (100.0) | 160 (100.0) |
Age at vaccination, years | |||||
Mean (SD) | 41.5 (12.83) | 70.2 (3.26) | 38.3 (13.20) | 71.3 (3.20) | 46.3 (16.55) |
Median (range) | 43.0 (20–63) | 71.5 (65–74) | 37.0 (20–60) | 70.5 (67–76) | 47.0 (20–76) |
